Table 4 Uro-oncological publications in Ovid MEDLINE (2001–2011)

Total publications

Prostatic neoplasms

46824

250.7 (214.2-287.2)

<0.0001

Kidney neoplasms

19152

106 (96.3-115.6)

<0.0001

Urinary bladder neoplasms

13736

40.8 (33.5-48.1)

<0.0001

Testicular neoplasms

5526

6 (-3.2-15.2)

0.17

Publications indexed as randomized controlled trials

Prostatic neoplasms

1404

8.1 (4.2-12)

0.001

Kidney neoplasms

193

1.9 (0.7-3)

0.005

Urinary bladder neoplasms

249

0.5 (-0.2-2.4)

0.09

Testicular neoplasms

39

0.1 (-0.2-0.5)

0.44

Publications indexed as clinical controlled trials

Prostatic neoplasms

129

0.2 (-1.6-1.2)

0.76

Kidney neoplasms

30

-0.3 (-0.6-0.1)

0.12

Urinary bladder neoplasms

41

-0.4 (-0.8-0)

0.05

Testicular neoplasms

6

-0.1 (-0.2-0)

0.15

Publications indexed as meta-analysis

Prostatic neoplasms

263

3 (2–3.9)

<0.0001

Kidney neoplasms

66

1.3 (0.7-1.9)

0.001

Urinary bladder neoplasms

128

1.6 (0.6-2.6)

0.006

Testicular neoplasms

30

0.4 (-0.1-0.8)

0.06

Publications indexed as case reports

Prostatic neoplasms

2232

0.5 (-3.5-4.4)

0.8

Kidney neoplasms

6013

22.6 (15.6-29.5)

<0.0001

Urinary bladder neoplasms

2304

0 (-3.4-3.5)

0.98

Testicular neoplasms

1817

0 (-4.3-4.4)

0.99